Cantor Fitzgerald reiterated its confidence in ORIC Pharmaceuticals (NASDAQ:ORIC), maintaining an Overweight stock rating.

Stratasys (NASDAQ:SSYS – Get Free Report)‘s stock had its “overweight” rating reiterated by analysts at Cantor Fitzgerald in a note issued to investors on Monday,Benzinga reports. They currently have ...

Cantor Fitzgerald raised the firm’s price target on PTC Therapeutics (PTCT) to $113 from $76 and keeps an Overweight rating on the shares. PTC ...

Howard Lutnick, the chairman of Cantor Fitzgerald and nominee for U.S. Commerce Secretary, faced questioning from Senate Democrats regarding the financial firm's investment in Tether, the entity ...

Cantor Fitzgerald CEO and Commerce Secretary nominee Howard Lutnick became visibly emotional at his confirmation hearing ...

US President Donald Trump signs an executive order to create a sovereign wealth fund with Scott Bessent, US Treasury ...

PTC Therapeutics (PTCT) is advancing 8% after investment bank Cantor Fitzgerald’ hiked its price target on the drug maker’s ...

Equities research analysts at Cantor Fitzgerald lifted their FY2025 earnings per share (EPS) estimates for KLA in a note issued to investors on Friday, January 31st. Cantor Fitzgerald analyst C. Muse ...

Commerce Secretary nominee Howard Lutnick defended Tether in a Senate hearing, arguing AI will "rid the world of criminals" ...

Howard Lutnick, President Donald Trump's nominee for Commerce Secretary and CEO of Cantor Fitzgerald, says the firm has no ...